Search Results - "Householder, Kyle T"
-
1
A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system
Published in Journal of controlled release (28-12-2015)“…In this work, we sought to test how surface modification of poly(lactic-co-glycolic acid) (PLGA) nanoparticles with peptide ligand alters the brain specific…”
Get full text
Journal Article -
2
CRMP2 Phosphorylation Drives Glioblastoma Cell Proliferation
Published in Molecular neurobiology (01-05-2018)“…Glioblastoma (GBM) is an aggressive primary brain tumor. The rapid growth and the privileged provenance of the tumor within the brain contribute to its…”
Get full text
Journal Article -
3
Curcumin-releasing mechanically adaptive intracortical implants improve the proximal neuronal density and blood–brain barrier stability
Published in Acta biomaterialia (01-05-2014)“…[Display omitted] The cellular and molecular mechanisms by which neuroinflammatory pathways respond to and propagate the reactive tissue response to…”
Get full text
Journal Article -
4
Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma
Published in International journal of pharmaceutics (20-02-2015)“…[Display omitted] Effective treatment of glioblastoma multiforme remains a major clinical challenge, due in part to the difficulty of delivering…”
Get full text
Journal Article -
5
pH driven precipitation of quisinostat onto PLA-PEG nanoparticles enables treatment of intracranial glioblastoma
Published in Colloids and surfaces, B, Biointerfaces (01-06-2018)“…[Display omitted] •Ionized quisinostat is loaded more efficiently onto PLA-PEG nanoparticles.•Quisinostat potency is maintained through nanoparticle…”
Get full text
Journal Article -
6
Abstract 1314: Evaluating payload delivery to the CNS from surface-modified nanoparticles
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…The blood-brain barrier (BBB) remains a major obstacle to treatment of intracranial tumors. Most drugs are poorly bioavailable in the brain, and peripheral…”
Get full text
Journal Article -
7
Optical barcoding of PLGA for multispectral analysis of nanoparticle fate in vivo
Published in Journal of controlled release (10-05-2017)“…Understanding of the mechanisms by which systemically administered nanoparticles achieve delivery across biological barriers remains incomplete, due in part to…”
Get full text
Journal Article -
8
A comparison of neuroinflammation to implanted microelectrodes in rat and mouse models
Published in Biomaterials (01-07-2014)“…Abstract Rat models have emerged as a common tool to study neuroinflammation to intracortical microelectrodes. While a number of studies have attempted to…”
Get full text
Journal Article -
9
EXTH-61. NANOPARTICLE DELIVERY TO THE SPINAL CORD VIA DIRECT ADMINISTRATION TO CEREBROSPINAL FLUID
Published in Neuro-oncology (Charlottesville, Va.) (01-11-2016)Get full text
Journal Article -
10
Abstract B21: Use of polymeric nanoparticles for the delivery of YM155 to glioma cells in vitro and in vivo
Published in Cancer research (Chicago, Ill.) (01-12-2015)“…YM155 (Sepantronium Bromide) is a potent survivin inhibitor that is the subject of clinical trials for multiple types of cancer including melanoma, lypmphoma,…”
Get full text
Journal Article -
11
Abstract 4579: Pathogen-derived targets for the delivery of chemotherapeutics to the brain
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…Introduction The blood-brain barrier (BBB) is a key obstacle to achieving better treatment of glioblastoma multiforme (GBM). Tight junctions in the BBB prevent…”
Get full text
Journal Article -
12
Abstract 1329: Intravenous delivery of Erlotinib-loaded PLA-PEG nanoparticles for treatment of GB
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Amplification, overexpression, and mutation of the epidermal growth factor receptor (EGFR) gene represent common genetic signature abnormalities (>50%) in…”
Get full text
Journal Article